Condition: CAD · Coronary Artery Disease · Coronary Stenosis · Sponsor: National Heart Centre Singapore
The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.
This description comes directly from the study's public registry record.
Associate Professor Zhong Liang · +65 6704 2237 · zhong.liang@nhcs.com.sg
Dr Lohendran Baskaran · lohendran.baskaran@singhealth.com.sg
Always discuss trial participation with your own doctor first.
| National Heart Centre Singapore | Singapore, Singapore | Recruiting |
| National University Hospital | Singapore, Singapore | Recruiting |
| Tan Tock Seng Hospital | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05509010